Author:
Luo Chao,Wang Xu,Mao Xiaoyuan,Huang Hanxue,Liu Yong,Zhao Jingping,Zhou Honghao,Liu Zhaoqian,Li Xiangping
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Adeneye AA, Agbaje EO, Olagunju JA (2011) Metformin: an effective attenuator of risperidone-induced insulin resistance hyperglycemia and dyslipidemia in rats. Indian J Exp Biol 49:332–338
2. Bai Z, Wang G, Cai S, Ding X, Liu W, Huang D, Shen W, Zhang J, Chen K, Yang Y, Zhang L, Zhao X, Ouyang Q, Zhao J, Lu H, Hao W (2017) Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: a network meta-analysis. Schizophr Res 185:73–79
3. Bilgic S, Korkmaz DT, Azirak S, Guvenc AN, Kocaman N, Ozer MK (2017a) Risperidone-induced renal damage and metabolic side effects: the protective effect of resveratrol. Oxidative Med Cell Longev 2017:8709521
4. Bilgic S, Tastemir Korkmaz D, Azirak S, Guvenc AN, Kocaman N, Ozer MK (2017b) The protective effect of thymoquinone over olanzapine-induced side effects in liver, and metabolic side effects. Bratislavske lekarske listy 118:618–625
5. Boyda HN, Procyshyn RM, Tse L, Hawkes E, Jin CH, Pang CC, Honer WG, Barr AM (2012) Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. J Psychiatry Neurosci 37:407–415
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献